Virpax Pharmaceuticals Inc (VRPX)
NASDAQ
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -8519.355 | -6067.89 | -1695.313 | -60.224 | -73.088 | -103.679 |
Return on Equity (%) | 442.749 | 168.51 | 124.928 | -72.476 | -80.094 | -164.101 |
Return on Invested Capital (%) | 440.235 | 162.14 | 132.806 | -70.948 | -80.812 | -169.503 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | -0.415 | -0.905 | -1.341 | 3.2 | 1.415 | 0.165 |
Earnings Per Share | -0.919 | -1.095 | -1.38 | -1.029 | -1.848 | -1.297 |
Cash Per Share | 0.017 | 0.014 | 0.017 | 3.145 | 1.622 | 0.78 |
Working Capital Per Share | -0.415 | -0.905 | -1.141 | 3.2 | 1.415 | 0.165 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.919 | -1.095 | -1.38 | -1.029 | -1.848 | -1.297 |
EBITDA Per Share | -0.919 | -1.095 | -1.38 | -1.029 | -1.848 | -1.297 |
Free Cash Flow Per Share | -0.919 | -1.095 | -1.38 | -1.029 | -1.848 | -1.297 |
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 2,87M | 3,02M | 3,15M | 11,72M | 11,71M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||
Actions en circulation | 11,71M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 1,61M |
Ratio cours/bénéfice | -0,11 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 0,18 |
Ratio prix/valeur comptable | 0,86 |
Rendement de dividende | - |
Actions en circulation | 4,89M |
Volume moyen (1 semaine) | 827,24k |
Volume moyen (1 mois) | 1,75M |
Variation sur 52 semaines | -90,14% |
Plus haut sur 52 semaines | 5,48 |
Plus bas sur 52 semaines | 0,286 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales